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ABSTRACT
Base excision repair (BER) is a frontline repair
system that is responsible for maintaining genome
integrity and thus preventing premature aging,
cancer and many other human diseases by repairing
thousands of DNA lesions and strand breaks con-
tinuously caused by endogenous and exogenous
mutagens. This fundamental and essential function
of BER not only necessitates tight control of the
continuous availability of basic components for
fast and accurate repair, but also requires temporal
and spatial coordination of BER and cell cycle pro-
gression to prevent replication of damaged DNA.
The major goal of this review is to critically
examine controversial and newly emerging ques-
tions about mammalian BER pathways, mechan-
isms regulating BER capacity, BER responses to
DNA damage and their links to checkpoint control
of DNA replication.
BASE EXCISION REPAIR: BASIC FACTS
DNA lesions arise owing to the intrinsic chemical instabil-
ity of the DNA molecule in the cellular milieu, which
results in hydrolytic loss of DNA bases, base oxidations,
non-enzymatic methylations and other chemical alter-
ations, as well as because of multiple reactions with ex-
ogenous (environmental) and endogenous (intracellular)
DNA reactive species (1,2). If left unrepaired, such
DNA alterations may interfere with DNA replication
and transcription, resulting in the accumulation of muta-
tions and a disturbance in cellular metabolism. Among the
many strategies to maintain a smooth operation and re-
production of the DNA blueprint, base excision repair
(BER) is an essential repair pathway that corrects
multiple DNA alterations that frequently occur in DNA.
BER deficiency affects genome stability and is implicated
in many human diseases, including premature aging (3),
neurodegeneration (4) and cancer (5). It is estimated that
every single human cell has to repair 10 000–20 000 DNA
lesions every day (1). Enzymes involved in BER recognize
damaged DNA bases and catalyze excision of the
damaged nucleotide and its replacement with a new
undamaged one. The majority of BER is accomplished
through the so-called short-patch BER and results in
removal and replacement of only one nucleotide (6–8).
Naturally, as nucleotide excision during BER leads to
the transient formation of a DNA single-strand break
(SSB), BER enzymes are also the major players in SSB
repair (9). BER reactions in cells are extremely fast, and
in many cases, an individual BER event may take only a
few minutes (10,11). The repair of acute DNA damage
requires several rounds of BER and can take several
hours, as the amount of BER enzymes is limited.
BASE EXCISION REPAIR: MECHANISMS AND
PATHWAYS
The major players involved in BER have been known for a
long time (12) and the entire BER process has been
reconstituted with purified enzymes (13,14). BER is
initiated by a damage-specific DNA glycosylase that
recognizes the damaged DNA base and cleaves the
N-glycosylic bond that links the DNA base to the sugar
phosphate backbone (15, Figure 1). Currently, 11 human
DNA glycosylases that recognize and excise a wide range
of DNA base damages are described (Supplementary
Table S1). The arising baseless site (also called abasic
site, apurinic/apyrimidinic site or AP site) is further pro-
cessed by an AP endonuclease (APE1 in human cells) that
cleaves the phosphodiester bond 50 to the AP site, thus
generating a SSB, also called a nick, containing a
hydroxyl residue at the 30-end and deoxyribose phosphate
at the 50-end.
At this point, the repair of damaged DNA bases con-
verges with SSB repair. To accomplish repair, the SSB
must have 30-hydroxyl and 50-phosphate ends that will
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allow a DNA polymerase to incorporate a new nucleotide
and DNA ligase to seal the DNA ends. In the ‘classic’ case
of BER that is initiated by the so-called monofunctional
DNA glycosylases, ligation of the SSB is prevented by the
50-deoxyribose phosphate. Therefore, DNA polymerase b
(Pol b) using its AP lyase activity removes this blocking
group (16) and simultaneously adds one nucleotide to the
30-end of the nick. To finalize DNA repair, the XRCC1–
DNA ligase IIIa complex seals the DNA ends (17–19).
Many other SSBs, arising endogenously or after muta-
genic insults, similarly contain unligatable ends that need
further processing. For example, repair of oxidative base
lesions is frequently initiated by DNA glycosylases that
have an associated b-lyase activity which, in addition to
removing damaged DNA base, also cleaves the phospho-
diester backbone 30 to the AP site to generate a nick with
30-a,b-unsaturated aldehyde (20,21). Formation of
blocking lesions is also apparent during BER conducted
by the Neil DNA glycosylases, which, in addition to the
DNA glycosylase activity, are also able to excise the
arising AP site by b,d-elimination, leaving a 30-phosphate
containing nick (22). DNA SSBs containing damaged
30-ends may also arise as a result of direct damage to
deoxyribose (23). Endogenous oxidative metabolism and
exogenous factors, such as ionizing radiation generating
reactive oxygen species, in addition to producing oxidative
DNA base modifications and AP sites, can also directly
induce SSBs with modified 50- and/or 30-ends (24). There
are also several other types of blocked SSBs generated by
aborted activity of DNA ligases or by DNA topoisomerase
I and II (25–27). Because the formation of non-canonical
SSBs blocks further repair, a group of DNA damage-spe-
cific enzymes cleans up the SSB ends and thereby prepares
them for DNA synthesis and ligation (Figure 1). The five
known SSB end-processors are (i) Pol b, which removes
blocking 50-sugar phosphates (16); (ii) APE1 that removes
30-sugar phosphates (28); (iii) Polynucleotide Kinase
Phosphatase (PNKP) that dephosphorylates 30-ends and
phosphorylates 50-hydroxyl ends (29); (iv) Aprataxin that
cleans 50-termini blocked by abortive ligation reactions (27)
and (v) tyrosyl DNA phosphodiesterases TDP1 that repair
SSBs generated by abortive DNA topoisomerase reactions
(26,30). These end-processing enzymes, separately or in
combination, can convert the SSB to a one-nucleotide
gap with 30-hydroxyl and 50-phosphate ends that can be
filled by Pol b and finally ligated by the XRCC1–DNA
ligase IIIa complex (Figure 1).
If the 50-ends are blocked and cannot be processed by
the five SSB end-processing enzymes mentioned above,
BER can be accomplished by the long-patch sub-pathway
(31–33). This pathway is also initiated by Pol b-dependent
incorporation of the first nucleotide into the nick and is
continued by enzymes borrowed from the lagging strand
replication machinery (34,35). The replicative Pol d con-
tinues strand displacement synthesis in the presence of
proliferating cell nuclear antigen and replication factor
C. The resulting flap of 2–12 nucleotides is cut off by
flap endonuclease 1 and the final nick sealed by DNA
ligase I (36).
BASE EXCISION REPAIR IS THE FOUNDATION OF
GENOME STABILITY
Although there is no convincing evidence for cell cycle
regulation of BER, based on the biochemical properties
of BER enzymes, the majority of which prefer double-
stranded DNA substrates, it is reasonable to assume
that BER mainly operates through the G1 phase of the
cell cycle. During G1, BER activity maintains error-free
transcription and prepares DNA for replication by
removing DNA lesions. However, if DNA base damage
is not removed before the initiation of DNA replication,
genome integrity is assured by a backup system called
translesion DNA synthesis (TLS) that involves specialized
Pols, which can perform error-free DNA synthesis over a
wide range of DNA base lesions (Figure 2). Human cells
possess 15 Pols, 11 of which are TLS Pols and 7 of these
are also proposed to function in BER (Supplementary
Table S2). The major BER enzyme for nuclear DNA is
Pol b, while Pol g is involved in BER of mitochondrial
DNA. Moreover, Pols d and e have been identified in
long-patch BER and Pols i,  and y were described to
contain AP lyase activities, suggesting a function in BER
(reviewed in 37). Indeed, Pol  is involved in the
MUTYH/Pol  BER sub-pathway [see below: Controlling
BER mechanisms by posttranslational modifications
(PTMs): future challenges]. The combination of seven
Pols with potential functions in BER and the fact that
Figure 1. Simplified scheme for the major base excision repair
pathway. ‘Blocked’ DNA strand breaks may arise as a result of
direct chemical modification during SSB formation or during enzymatic
processing of DNA base damage by a DNA glycosylase and
AP-endonuclease. A SSB containing a one nucleotide gap with
30-hydroxyl and 50-deoxyribose phosphate ends is recognized by Pol
b, which fills the gap, removes the 50-deoxyribose phosphate and
recruits XRCC1–DNA ligase IIIa complex to seal the DNA ends
(‘classic’ BER pathway, left branch of the scheme). Strand breaks con-
taining other DNA ends blocking modifications are recognized by the
corresponding damage-specific protein that converts 50- and/or 30-ends
into the conventional 50-phosphate and 30-hydroxyl ends and further
recruits Pol b and XRCC1-DNA ligase IIIa to accomplish repair (right
branch of the scheme). Among the known damage-specific protein are
Pol b, APE1, PNKP, TDP1, TDP2 and aprataxin.
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11 Pols can perform TLS guarantee reliable backup to
BER for the maintenance of efficient and accurate repair
of DNA base lesions. This conclusion is supported by the
observation that all DNA glycosylase knockout mice
(with exception of thymine-DNA glycosylase) are viable
and fertile (38), even though they accumulate unrepaired
DNA base lesions during their life time, suggesting that
the ‘base correction’ function of BER is strongly backed
up by TLS (39). However, SSBs unrepaired by BER have
the potential to hit the DNA replication fork and to
generate DNA double-strand breaks (DSBs) (40), which
require either non-homologous end joining (NHEJ) or
homologous recombination (HR) for repair (Figure 2).
The question is how much backup repair capacity can
NHEJ and HR provide to preserve genome stability?
Probably not that much because all attempts to generate
mice deficient in Pol b, DNA ligase IIIa or XRCC1,
involved in the repair of SSBs, resulted in early embryonic
lethality (41–43). Even haploinsufficiency (inactivation of
one gene allele) in the Pol b gene leads to significant
genome instability and sensitivity to DNA damage, sug-
gesting that BER is the key cellular system responsible for
the repair of SSBs (44).
COORDINATION OF BASE EXCISION REPAIR
There are at least two major mechanisms for the coordin-
ation of BER reactions that have been extensively discussed
in the literature. One mechanism is based on transient
protein–protein interactions, while the other suggests
preexisting stable repair complexes. The idea that the co-
ordination of the DNA repair process is initiated at early
stages was proposed by several groups (45–47). Multiple
interactions between BER proteins demonstrated by
co-immunoprecipitation, GST-pull downs and a yeast
two-hybrid system inspired the ‘passing the baton’ model
of BER, which suggests that the repair intermediates of the
BER pathway are passed on from one protein to the next in
a coordinated manner (48,49). Based on this hypothesis, a
damaged DNA base would be passed during the course of
repair from a DNA glycosylase, to APE1, to Pol b, and
finally to the XRCC1–DNA ligase IIIa complex. The
‘passing the baton’ model provides a well-balanced mech-
anism for the coordination of the ‘classic’ short-patch BER
pathway involved in, for example, the repair of uracil in
DNA. However, this model does not properly describe the
repair of many other DNA base lesions. Even for the repair
of oxidative base lesions, it would be difficult to explain
how and why a smooth chain of reactions is changed, as
the ‘baton’ would need to be passed to one of the DNA
damage end-processors.
Several early models also suggested that BER is a con-
tinuous process that is performed from the beginning to the
end by preassembled DNA repair complexes (45,47). This
idea was based on a number of co-immunoprecipitation
experiments demonstrating numerous interactions
between BER proteins and suggesting that they function
in multiprotein complexes [reviewed in (46)]. However,
direct attempts to purify repair complexes that are stable
in physiological conditions were unsuccessful (50). Because
the same subset of BER enzymes (including 11 DNA
glycosylases, AP endonuclease, 5 end-processors, 7 Pols
and 2 DNA ligases) is involved in the repair of a variety
of DNA lesions including damaged DNA bases, AP sites
and SSBs of a different nature, it is difficult to imagine
that the repair process will be accomplished by a few
preexisting DNA repair complexes. Such a variety of dif-
ferent DNA lesions require a DNA repair response tailored
to a specific type of DNA damage. Thus, it is reasonable to
assume that DNA glycosylases, independent from the rest
of BER proteins, are persistently performing high-speed
scanning of DNA, removing damaged DNA bases and
creating AP sites without nucleation of the DNA repair
complexes. Indeed, recent studies on the mechanisms of
DNA base recognition and excision by DNA glycosylases
support this idea (51,52). Because BER is not the only
source of AP sites and a significant proportion of AP
sites arises as a result of spontaneous loss of DNA bases,
it is also reasonable to conclude that APE1 operates inde-
pendently from the rest of BER proteins in AP site incision.
However, most probably, further repair of SSBs is
coordinated by specific protein–protein interactions. This
should be initiated by the DNA damage-specific
end-processor proteins, all of which are strongly interacting
either with Pol b or XRCC1-Ligase IIIa (4,46) to allow
formation of the DNA damage-specific complexes on
DNA. As a result, all of these complexes will have a Pol
b and XRCC1-DNA ligase IIIa component, in addition to
the DNA damage-specific protein. Indeed, formation of
such specific complexes was demonstrated for BER in
whole cell extracts by protein formaldehyde crosslinking
during repair of SSBs (53).
REGULATION OF SSB REPAIR CAPACITY AND
PREVENTION OF DNA DOUBLE-STRAND BREAKS
To survive the challenge of environmental or physiological
stress, living systems require the ability to modulate the
capacity of BER in response to an increased level of DNA
Figure 2. Base excision repair backup involves translesion synthesis
and DSB repair pathways. BER is mainly accomplished in the G1
phase of the cell cycle and is also supported by other DNA repair
pathways through the cell cycle. A small proportion of DNA base
lesions, those which are left unrepaired or generated just before the
initiation of replication, are tolerated by TLS. Repair of DSBs
arising owing to replication over unrepaired SSBs is accomplished by
NHEJ or HR.
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damage. Most importantly, they should be able to effi-
ciently recognize and repair SSBs to avoid massive forma-
tion of DSBs that may overload the cellular DSB repair
capacity and eventually lead to cell death. Although mam-
malian cells have limited amounts of BER enzymes, they
are able to recover from acute DNA damage that is sig-
nificantly above the ‘physiological’ level. This suggests
that mechanisms for instant modulation of BER
capacity exist. It has been known for some time that
Poly(ADP-ribose) Polymerase 1 (PARP1) molecules bind
to SSBs within a few seconds, which activates synthesis of
poly(ADP-ribose) polymers and subsequently allows
PARP1 to dissociate from DNA (54). Two major
models have been proposed to link this PARP1 activity
to the BER pathway. First, several groups suggested that
poly(ADP-ribosyl)ated PARP1 may recruit BER proteins
directly to the DNA damage site, which would impact the
DNA repair capacity by providing efficient recognition of
SSBs (55,56). However, the results of the experiments
testing the role of PARP1 in BER efficiency are contra-
dictory, with some groups finding reduced repair activity
in PARP1 depleted cell extracts, while others do not [re-
viewed in (57)]. One of the earliest models for the role of
PARP1 in BER was proposed by Lindahl’s group (58).
Because their results did not support the idea that
PARP1 is required for DNA damage processing, they
proposed that PARP1 is involved in protecting DNA
SSBs from deterioration by cellular nucleases. Later,
Dianov’s group also found that although a deficiency of
PARP1 does not affect the efficiency of BER reactions
(59) and the recruitment of key BER enzymes to sites of
DNA damage (60), PARP1 indeed protects DNA SSBs
from cellular nucleases (61). Interestingly, PARP1 knock-
out mice are hypersensitive to alkylating agents and irradi-
ation (62,63). The fact that PARP1 knockout mice
develop normally but are sensitive to mutagens suggests
that their repair capacity is barely efficient enough to deal
with endogenous DNA lesions, but not sufficient to deal
with an increased load of DNA damage. It was later
proposed (57) that if the molar amount of DNA SSBs
exceeds the molar amount of BER enzymes required for
repair, PARP1 dimers bind and protect these SSBs from
deterioration into more lethal lesions, such as DSBs.
Subsequently, PARP1 auto-modification and accumula-
tion of a negatively charged poly(ADP-ribose) chains
causes its dissociation from the DNA, allowing BER
proteins that are released from the first round of repair
to access the SSB to undergo next round of DNA repair
(Figure 3). This cycle is repeated whereby PARP1 mol-
ecules cycle on and off the DNA and protect the SSBs
until repair is accomplished. Because PARP1 is an
abundant cellular protein, this mechanism assures an
increase in the repair capacity of the cell, thus preventing
formation of more deleterious DSBs.
REGULATORY STRATEGIES IN BASE EXCISION
REPAIR: THE GOAL IS TO FIT THE NEED
Individual and tissue variations in BER gene expression
are significant (64), suggesting that up and down
regulation of BER is taking place in response to the
cellular environment. Because BER is primarily and con-
tinuously required by mammalian cells for the repair of
endogenously generated lesions, BER activity is regulated
to a steady-state level rather than through a mechanism
that switches the pathway on and off. To support the
error-free gene transcription and replication, steady-state
levels of BER enzymes should secure efficient and timely
repair of fluctuating amounts of endogenous DNA lesions
specific to a particular cell type, or those arising under
certain persistent conditions such as hypothermia,
hypoxia and inflammation. Indeed, mutations affecting
the amounts or enzymatic activities of BER proteins
increase genome instability and reduce cell viability
(65–67). On the other hand, the amount of BER
enzymes should be tightly controlled because their over-
production may affect other DNA transactions and also
lead to genome instability and cancer (68–71). To support
an adequate level of BER enzymes, cells use an elegant
mechanism that links the steady-state levels of BER
enzymes to the levels of endogenous DNA damage. This
is achieved by stabilization of the key BER enzymes (Pol
b, and XRCC1-DNA ligase IIIa) that are conducting
DNA repair, and proteasomal degradation of excessive
proteins that are not involved in DNA repair. It was
recently demonstrated that degradation of excessive
BER proteins is supported by two E3 ubiquitin ligases.
First, Mule/ARF-BP1 monoubiquitylates unwanted
BER proteins and, consecutively, CHIP extends the ubi-
quitin chain and thus labels proteins for proteasomal deg-
radation (72,73). The control of Mule activity is
accomplished by the acute rheumatic fever (ARF)
protein, which accumulates in response to DNA damage
(74,75). ARF binds to and inhibits Mule activity (76), thus
reducing the rate of Mule-dependent ubiquitylation and
CHIP-promoted degradation of BER enzymes. The con-
comitant accumulation of BER enzyme levels leads to
Figure 3. Model explaining the role of PARP1 in the modulation of
BER capacity. PARP1 binds and protects SSBs that cannot be repaired
immediately owing to excessive SSBs and repair enzyme limitation (Pol
b, DNA ligase IIIa–XRCC1 complex) (right branch). PARP1 is
activated on binding to SSB and its autopoly(ADP ribosyl)ation
leads to its release from the DNA. This allows BER proteins that are
released from the previous round of repair (left branch) to access the
SSB and complete the repair process. If unrepaired SSBs remain,
PARP1 can cycle on and off the DNA and protect the SSBs until
sufficient repair proteins are available. This mechanism increases the
repair capacity of BER and prevents the formation of more deleterious
DNA DSBs.
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increased DNA damage repair. This in turn results in a
reduced level of DNA lesions, reduced release of ARF,
activation of Mule and ubiquitylation-dependent degrad-
ation of BER enzymes (Pols b and  (73,77)), thus
completing a whole cycle of DNA damage signaling and
modulation of BER proteins required for DNA repair
(Figure 4). Theoretically, the cellular pool of BER
enzymes should include several components: (i) newly
synthesized proteins located in the cytoplasm, (ii)
enzymes relocated to the nucleus but not yet associated
with chromatin and (iii) chromatin-associated proteins
involved in DNA repair. The dynamics of this pool are
controlled by the cytoplasmic protein Mule, and the
nuclear protein ARF that acts as a messenger reporting
on the state of DNA repair and controlling Mule activity.
Correspondingly, the steady-state levels of BER enzymes
are determined by a dynamic equilibrium of all these
processes (72,73).
ARF LINKS DNA DAMAGE SIGNALING, REPAIR
AND REPLICATION
Although the exact mechanism of ARF induction by
DNA damage is still unclear, recent studies support the
idea that ARF is a DNA damage reporter (74,75). As we
discussed above, ARF interacts with Mule, inhibits
its activity and thus up regulates the flow of BER
enzymes into the nucleus to support efficient DNA
repair (Figure 4). Indeed, it was shown that ARF
knockdown by siRNA reduces the rate of DNA repair,
while Mule deficiency stimulates it (73). However, it was
also demonstrated that ARF induction delays cell cycle
progression through the inhibition of the two E3 ubiquitin
ligases Mule and Mdm2, which promote p53 ubiquityla-
tion and proteasomal degradation in the absence of DNA
damage (76). Taken together, these data indicate that
ARF links DNA damage repair and DNA replication.
On DNA damage, ARF is induced and thus enhances
BER activity through inhibition of Mule and simultan-
eously, by licensing p53 accumulation, delays DNA repli-
cation and cell cycle progression to allow more time for
the cell to accomplish DNA repair (Figure 5).
CONTROLLING BER MECHANISMS BY
POSTTRANSLATIONAL MODIFICATIONS:
FUTURE CHALLENGES
It is evident that the most relevant and elegant way to
regulate BER proteins is through various PTMs. These
can influence BER proteins at different levels: (i) at the
activity level, (ii), at the protein stability level, (iii) at the
protein–protein interaction level, (iv) at the cellular local-
ization level, (v) at the transcriptional level and (vi) at
the chromatin level. The main PTMs in the regulation of
BER proteins identified to date include phosphorylation,
acetylation, ubiquitination, SUMOylation and methyla-
tion (Supplementary Table S1 and references therein).
Although exciting, at the moment this is still an
emerging area with many interesting, but disconnected,
observations that have not yet been integrated into a com-
prehensive picture of BER regulation. Nevertheless, some
interesting crosstalks between different BER PTMs have
been discovered.
As an example for such a crosstalk between two PTMs,
we describe the data from our two laboratories on the
Figure 4. Regulation of steady-state levels of BER enzymes by Mule,
CHIP E3 ligases and ARF. Newly synthesized BER proteins are either
transported to the nucleus to take part in DNA repair or, if not
required for DNA repair, they are ubiquitylated by Mule and then
targeted for proteasomal degradation after CHIP-mediated
polyubiquitylation. However, following detection of DNA damage,
ARF is accumulated and inhibits the activity of Mule, thus reducing
BER protein degradation and up regulating nuclear levels of BER
enzymes, which elevates DNA repair. Consequently, the repair of
DNA damage will result in a decreased release of ARF and a concomi-
tantly increased activity of Mule that down regulates BER protein
levels. A new adjustment cycle will therefore begin on the detection
of increased levels of DNA damage. Adapted from ref. 73.
Figure 5. BER is a part of the p53-ARF network controlling genetic
stability. BER activity and DNA replication delay are regulated by the
same proteins. Detection of DNA damage results in the accumulation
of ARF, which activates two cellular processes. By inhibiting Mule, it
stabilizes BER proteins and activates DNA repair. At the same time,
inhibition of Mule and Mdm2 by ARF leads to an accumulation of p53
and results in a cell cycle delay. After DNA repair is accomplished, the
reduction in DNA damage initiates a reverse cycle by reducing DNA
repair and releasing the cell for replication.
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regulation of Pol  by phosphorylation and ubiquityla-
tion. The misincorporation of adenosine monophosphate
(A) by the replicative Pols a, d and e opposite to 8-oxo-G
is removed by a specific DNA glycosylase called
MUTYH, leaving the 8-oxo-G lesion on the DNA.
Subsequent incorporation of C opposite 8-oxo-G in the
resulting gapped DNA is essential for the further removal
of the 8-oxo-G by BER to prevent G-C to T-A transver-
sion mutations (78). In the presence of RP-A and PCNA,
Pol  incorporates a correct C 1200-fold more efficiently
than Pol b (79) and is thus important for this branch of
BER. Because Pol  is mainly required for post replication
DNA repair, it was reasonable to assume that its expres-
sion is coordinated with the cell cycle. Indeed, the
cyclin-dependent kinase Cdk2 was identified, in a prote-
omic approach, as a novel interaction partner of Pol  (80)
and was later found to phosphorylate Pol  in vitro. It was
also found that the Pol  phosphorylation pattern during
cell cycle progression mimics the modulation of the Cdk2/
cyclin A activity profile. Phosphorylation of threonine-553
is critical for maintaining Pol  stability, as dephosphory-
lated protein is targeted to the proteasomal degradation
pathway via ubiquitylation by E3 ligase Mule (81). In par-
ticular, Pol  is phosphorylated and stabilized during cell
cycle progression in late S and G2 phase, exactly at the
point when Pol -dependent repair should occur.
CONCLUSIONS
It is conceivable that BER proteins have to be tightly
controlled depending on the physiological, and even patho-
logical, situation of a cell. Although we are just beginning to
understand how the essential BER pathways and its many
involved factors are regulated, BER emerges as the major
repair system maintaining genome stability over a lifespan.
A complete lack of BER is incompatible with life and a
misregulation of BER has been implicated in cancer, neuro-
pathology, aging and several other human diseases.
Finally, BER is not an isolated pathway but should be
considered as a part of an intricately regulated system that
identifies DNA damage, controls DNA repair and coord-
inates the entire process with cell cycle progression to
prevent replication of damaged DNA, and thus guards
genome stability. This is achieved by a sophisticated regu-
latory network that is orchestrated by multiple PTMs,
which in turn regulate gene expression, protein stability
and interactions of cellular proteins.
Although the entire picture of BER regulation is not yet
clear, it is evident that most BER proteins are subject to at
least one PTM contributing to the regulatory mechanism.
It is also clear that a more definitive picture of cellular
BER regulation will be obtained once the opposing
reaction enzymes (phosphatases, deubiquinating enzyme,
deacetylases and demethylases) are identified.
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